Survival rates for chronic myeloid leukemia
Some people with cancer may want to know the survival rates for their type of cancer. Others may not find the numbers helpful, or may even not want to know them. If you decide that you don’t want to know them, stop reading here and skip to the next section.
New drugs that seem to work well to treat most cases of CML were first used in 2001. We do not yet know how long patients treated with these drugs may live. We do know that most patients who have been treated with these drugs responded well.
One large study of patients with CML treated with imatinib (Gleevec) found that about 90% of patients were still alive 5 years after starting treatment. Most of these patients had normal white blood cell counts at 5 years.
Last Medical Review: 08/13/2013
Last Revised: 08/13/2013